Sixteen months after forging a strategic collaboration, Gilead Sciences has announced its definitive agreement to acquire German biotechnology firm Tubulis,…
Read More
Penn Engineering and CHOP Researchers Develop Advanced Bone Marrow on a Chip to Revolutionize Drug Development and Space Medicine
In a significant leap for bioengineering and regenerative medicine, a collaborative team from the University of Pennsylvania School of Engineering…
Read More
JAMA Study Links Moderate Caffeine Intake to Lower Dementia Risk, Providing a Potent Nudge for Adenosine Pathway Drug Hunters
A comprehensive prospective cohort study, published online February 9, 2026, in the prestigious journal JAMA, has unveiled compelling evidence suggesting…
Read More
International Researchers Uncover Crucial Protein in Malaria Parasite Life Cycle, Offering New Hope for Drug Development
Researchers from a consortium of international institutions have made a significant breakthrough in understanding the complex life cycle of the…
Read More
Evogene, Systasy and LMU University Hospital Munich team up on AI-driven drug discovery for inflammatory diseases
An ambitious new international collaboration, bolstered by a prestigious pan-European EUREKA grant, is set to revolutionize the treatment landscape for…
Read More
Terray’s TerraBind Delivers 26x Faster Inference and Enhanced Accuracy, Challenging Diffusion-Based AI Models in Drug Discovery
In a significant development poised to reshape the landscape of AI-driven drug discovery, Terray Therapeutics, a Los Angeles-based startup, has…
Read More
How Digital Tools and AI Are Accelerating Drug Discovery
The landscape of pharmaceutical innovation has long been characterized by arduous timelines, exorbitant costs, and a high probability of failure,…
Read More
Closing the Information Gap: ETH Zurich Team Integrates Function and Binding in One Drug Screening Assay
A pioneering team of researchers from ETH Zurich and Karolinska Institutet has unveiled a groundbreaking cross-linking MALDI mass spectrometry (MS)…
Read More
Can live cell dynamics fix drug discovery’s efficacy problem?
The pharmaceutical industry, perpetually navigating a landscape of escalating costs and protracted timelines, faces a critical juncture where innovation is…
Read More
From list price to net price: How finance leaders decode real drug costs
In the complex landscape of the healthcare industry, public discourse surrounding drug pricing frequently begins and ends with the list…
Read More
